RCM
PRDS

Radcliffe Capital Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Radcliffe Capital Management’s Portfolio PRDS Stock Details PRDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$499K – 944
2021
Q2 		$499K Hold
50,000
– – 0.02% 845
2021
Q1 		$498K Buy
+50,000
New +$498K 0.02% 643